The Senescence Program is Reduced in Proteasome Inhibitor Bortezomib-Resistant PC3 Prostate Cancer Cell Line

Objective: Senescence may act as an antitumor mechanism by preventing the proliferation of cancer cells. Here we investigated the hypothesis that PC3 prostate cancer cells resistant to bortezomib respond differently to proteasomal inhibition with respect to induction of the senescence program as com...

Full description

Saved in:
Bibliographic Details
Main Authors: Ertan Kanbur, Semih Şeker, Ferah Budak, Azmi Yerlikaya
Format: Article
Language:English
Published: Istanbul University Press 2023-06-01
Series:European Journal of Biology
Subjects:
Online Access:https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/B218A92BA9454949935DB450BDB7C8DC
Tags: Add Tag
No Tags, Be the first to tag this record!